State of New Hampshire v. Allergan Limited et al. Consent Judgment Sept 2023
Watson Laboratories Inc Released from NH Opioid Claims
Trusted by teams at
Description
Under a consent judgment in New Hampshire, Watson Laboratories, Inc. is included among those entities released from opioid litigation claims. The company is covered by the terms of annual payments and injunctive relief as set out in the national opioid settlement.
Contract Details
Contract Amount
See Allergan Public Global Opioid Settlement Agreement; included as released entity in global settlement not exceeding $2,372,972,184.12. New Hampshire share not disaggregated.
Vendor
WATSON LABORATORIES INC
Agency
New Hampshire AG | (Domestic Violence Fatality Review Committee), NH
Contract Type
OTHER
Document Date
September 12, 2023
Contract Term
Annual payments beginning 2023 through 2029 (July 15, 2029 is final scheduled payment)
Renewal Date
2029-07-15
Renewal Info
Case settlement is not subject to renewal; amendments require mutual written agreement plus court approval.
Issuing Agency
New Hampshire AG | (Domestic Violence Fatality Review Committee)
State
Concord, NH
More from New Hampshire AG | (Domestic Violence Fatality Review Committee)
New Hampshire Victim Services Funding RFP SFY27VS01 March 2026
State of New Hampshire v. Publicis Health, LLC Assurance of Discontinuance Feb 2024
Merrimack Superior Court Consent Judgment and Dismissal Teva Global Opioid Settlement 2023-09-12
Merrimack Superior Court Consent Judgment and Dismissal Teva Global Opioid Settlement 2023-09-12
State of New Hampshire v. Allergan Limited et al. Consent Judgment Sept 2023
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.